X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
https://www.raps.org/news-and-articles/news-articles/2018/3/merck,-j-j-and-allergan-seek-changes-on-fda-draft
https://www.fiercepharma.com/marketing/opdivo-repatha-and-lynparza-likely-among-china-s-2018-blockbuster-nods-report
http://www.prnewswire.com/news-releases/abbvie-announces-fda-acceptance-of-new-drug-application-for-a-once-daily-formulation-of-viekira-pak-ombitasvir-paritaprevir-and-ritonavir-tablets-dasabuvir-tablets-to-treat-genotype-1-chronic-hepatitis-c-virus-infection-300186528.html
http://www.prnewswire.co.uk/news-releases/abbvie-demonstrates-commitment-to-hepatitis-c-patients-with-new-data-on-viekira-pak-ombitasvir-paritaprevir-ritonavir-tablets-dasabuvir-tablets-and-ongoing-clinical-development-program-at-the-liver-meeting-2015-530280381.html
http://www.prnewswire.com/news-releases/abbvies-viekirax-ombitasvirparitaprevirritonavir-tablets-receives-approval-in-japan-for-the-treatment-of-genotype-1-chronic-hepatitis-c-300149653.html
http://www.pharmatimes.com/Article/15-06-10/NHS_England_stumps_up_%C2%A3190m_for_hep_C_therapy.aspx
http://www.fiercepharma.com/story/hep-c-landscape-shifts-again-bms-combo-nabs-breakthrough-tag/2015-05-20
http://www.fiercepharma.com/story/ranks-super-spender-patients-triple-pushing-drug-bills-52b/2015-05-13
http://www.fiercepharma.com/story/gilead-ready-take-cash-hep-c-superstars-and-buy-something/2015-05-01
http://www.fiercepharmamarketing.com/story/abbvie-says-disappointing-viekira-sales-numbers-are-misleading/2015-04-27
http://ir.enanta.com/phoenix.zhtml?c=147990&p=irol-newsArticle&ID=2039274
http://www.fiercepharma.com/story/abbvie-moves-closer-japans-crowded-hep-c-field-priority-review-nod/2015-04-16
http://www.fiercepharma.com/story/medicaid-drug-spending-hikes-rile-lawmakers-theres-no-end-sight/2015-04-13
http://www.wsj.com/articles/gileads-1-000-hep-c-pill-is-hard-for-states-to-swallow-1428525426
http://www.fiercepharma.com/story/watch-out-two-front-hep-c-price-war-when-mercks-combo-hits/2015-04-08
http://www.fiercepharma.com/story/heavyweight-pbms-mean-trouble-big-pharmas-pricey-new-meds/2015-03-31
http://blogs.wsj.com/pharmalot/2015/03/23/gilead-warning-of-hep-c-patient-death-on-heart-med-will-have-zero-impact/
http://images.info.science.thomsonreuters.biz/Web/ThomsonReutersScience/%7B7e677448-1313-40ae-9978-6be1a8532a08%7D_A4_MarketInsight_Report_0213_012__edits_2.pdf
http://blogs.fda.gov/fdavoice/index.php/2015/03/fda-continues-to-lead-in-precision-medicine/
http://www.fiercepharma.com/story/big-pharmas-market-cap-stars-2014-lilly-abbvie-astrazeneca/2015-03-19
http://www.fiercepharma.com/story/drug-spending-surged-13-last-year-pricey-hep-c-meds-leading-charge/2015-03-10
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/003839/WC500184000.pdf
http://in.reuters.com/article/2015/02/26/bristolmyers-hepatitis-idINL1N0W02MF20150226
http://www.fiercepharma.com/story/gilead-looks-overseas-guard-profits-hep-c-blockbuster-sovaldi/2015-02-27
http://www.fiercepharmamarketing.com/story/crown-new-drug-launch-king-gileads-harvoni-has-knocked-aside-sister-med-sov/2015-02-18
http://www.fiercepharma.com/story/say-what-cvs-health-execs-figure-pcsk9-meds-cost-150b/2015-02-17
http://www.fiercepharma.com/story/humira-biosimilars-will-gut-abbvies-sales-3-years-analyst-says/2015-02-10
http://www.fiercepharma.com/story/gileads-pricey-sovaldi-lost-patent-india-now-its-eu-patent-under-siege/2015-02-10
http://www.reuters.com/article/2015/02/10/gilead-hepatitis-europe-idUSL1N0VK2JG20150210
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/003837/WC500182236.pdf
Market Place
Share 
